Physiologically Based Pharmacokinetic Model Incorporating Enterohepatic Circulation of Multi-kinase Inhibitor Regorafenib to Explain Prolonged Exposure After Single and Repeated Dosing
Drug Metabolism and Disposition · 2026-11 · 100436
DOI: 10.1016/j.dmd.2026.100436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-11. Verfasst von Ruth Shekina Lumumba und 8 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lumumba, R. S., Masuo, Y., Kono, F., Yoshikado, T., Kubota, Y., Doi, A., Chiba, K., Fujita, K., & Kato, Y. (2026). Physiologically Based Pharmacokinetic Model Incorporating Enterohepatic Circulation of Multi-kinase Inhibitor Regorafenib to Explain Prolonged Exposure After Single and Repeated Dosing. Drug Metabolism and Disposition, 100436. https://doi.org/10.1016/j.dmd.2026.100436
Vancouver
Lumumba RS, Masuo Y, Kono F, Yoshikado T, Kubota Y, Doi A, et al. Physiologically Based Pharmacokinetic Model Incorporating Enterohepatic Circulation of Multi-kinase Inhibitor Regorafenib to Explain Prolonged Exposure After Single and Repeated Dosing. Drug Metabolism and Disposition. 2026:100436. doi:10.1016/j.dmd.2026.100436
BibTeX
@article{Lumumba2026,
author = {Lumumba, Ruth Shekina and Masuo, Yusuke and Kono, Fukino and Yoshikado, Takashi and Kubota, Yutaro and Doi, Akito and Chiba, Koji and Fujita, Ken-ichi and Kato, Yukio},
title = {Physiologically Based Pharmacokinetic Model Incorporating Enterohepatic Circulation of Multi-kinase Inhibitor Regorafenib to Explain Prolonged Exposure After Single and Repeated Dosing},
journal = {Drug Metabolism and Disposition},
year = {2026},
pages = {100436},
doi = {10.1016/j.dmd.2026.100436}
}
EUVIMED